Increasing resistance to quinolones: A four-year prospective study of urinary tract infection pathogens

26Citations
Citations of this article
44Readers
Mendeley users who have this article in their library.

Abstract

A four-year prospective study was carried out to determine the incidence and rate of development of resistance by common urinary tract infection (UTI) pathogens to quinolone antimicrobial agents. Results show that there is high intrinsic resistance to the quinolones among strains of Pseudomonas aeruginosa (43.4%), Escherichia coli (26.3%), and Proteus spp. (17.1%). Over four years, rising rates of resistance were observed in P. aeruginosa (14.6% increase), Staphylococcus aureus (9.8%), and E. coli (9.7%). The highest potency was exhibited by ciprofloxacin (91.2%), levofloxacin (89.2%), and moxifloxacin (85.1%), while there were high rates of resistance to nalidixic acid (51.7%) and pefloxacin (29.0%). Coliforms, particularly E. coli (>45%), remain the most prevalent causative agents of UTI while females within the age range of 20-50 years were most vulnerable to UTI. © 2009 Omigie et al, publisher and licensee Dove Medical Press Ltd.

Cite

CITATION STYLE

APA

Omigie, O., Okoror, L., Umolu, P., & Ikuuh, G. (2009). Increasing resistance to quinolones: A four-year prospective study of urinary tract infection pathogens. International Journal of General Medicine, 2, 171–175. https://doi.org/10.2147/ijgm.s2641

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free